Area of research
Epidemiology · Geriatrics and Gerontology
Research interest
Research interests include Nonalcoholic fatty liver disease, Internal medicine, Oxidative stress, Chemistry, SIRT6, and Microglia.
Corrigendum to “Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway” [J. Ethnopharmacol. 279 (2021) 114340]
Hepatocyte-specific SLC27A4 deletion ameliorates nonalcoholic fatty liver disease in mice via suppression of phosphatidylcholine-mediated PXR activation
Cassia mimosoides L. decoction improves non-alcoholic fatty liver disease by modulating the pregnane X receptor
Microglia Sirt6 modulates the transcriptional activity of NRF2 to ameliorate high-fat diet-induced obesity
Harnessing the Therapeutic Potential of Ginsenoside Rd for Activating SIRT6 in Treating a Mouse Model of Nonalcoholic Fatty Liver Disease
Pachymic acid modulates sirtuin 6 activity to alleviate lipid metabolism disorders
Correction: Microglia Sirt6 modulates the transcriptional activity of NRF2 to ameliorate high-fat diet-induced obesity
Ginsenoside Rc Modulates SIRT6-NRF2 Interaction to Alleviate Alcoholic Liver Disease
Hepatic SIRT6 Modulates Transcriptional Activities of FXR to Alleviate Acetaminophen-induced Hepatotoxicity
Ginsenoside Rc, as an FXR activator, alleviates acetaminophen-induced hepatotoxicity via relieving inflammation and oxidative stress
Microglia Sirt6 modulates transcriptional activity of NRF2 to defend high fat diet-induced obesity
Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway
A Sensitive Liquid Chromatography-Mass Spectrometry Method for Determination of Toosendanin in Rat Plasma and its Application to Pharmacokinetic Study